Results per Page:
Switching Off to Survive: Unraveling KAT5’s Control of Glioblastoma Dormancy
From the Paddison Lab, Human Biology Division
From the bench to Hutch services: Refining gene-editing methods for HSPCs used in pre-clinical applications
From the Paddison lab, Human Biology Division
Searching beyond the streetlight to uncover functional protein domains
From the Paddison Lab, Human Biology Division
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Methylation marks make the difference in erythropoiesis
From the Paddison lab, Human Biology Division
Scientists discover new process shaping red blood cell development
Finding could shed new light on causes of certain cancers, anemias
Getting to the heart of complex cancer mutations
From the Clurman lab, Human Biology Division
Good News: Dr. Cyrus Ghajar receives $1M from Keck Foundation to study why cancer doesn’t spread to skeletal muscle
Celebrating faculty and staff achievements
New potential treatment target for small-cell lung cancer identified
Mouse study identifies gene that promotes tumor development, shows potential of drug inhibitor to slow cancer progression
Good News at Fred Hutch
Celebrating faculty and staff achievements